A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

NCT05332366 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Frontal Fibrosing Alopecia

Interventions

DRUG: Delgocitinib cream
DRUG: Delgocitinib cream vehicle

Sponsor

LEO Pharma